Health · 5 views
Novel siRNA Therapeutic Cuts Liver Fat in MASLD, Early Trial Shows
(MedPage Today) -- One dose of a novel small interfering RNA (siRNA) therapy -- CIDEBsiRNA (also known as ALN-CIDEB) -- led to normal liver fat content and lower alanine aminotransferase (ALT) levels in most patients with metabolic…
Summary
(MedPage Today) -- One dose of a novel small interfering RNA (siRNA) therapy -- CIDEBsiRNA (also known as ALN-CIDEB) -- led to normal liver fat content and lower alanine aminotransferase (ALT) levels in most patients with metabolic dysfunction
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- Going to the park at least once a week can improve children's mental healthContinue reading
- Disabled people in England ‘have to wait up to two years for wheelchairs’Continue reading
- Study identifies antidepressants that get patients well and keep them wellContinue reading
- Why does cancer rarely spread to the heart? Researchers develop organ-on-a-chip platform to find outContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow